← back to search

George Q. Daley

Harvard University · US
Area of research
Molecular Biology · Cell Biology
Research interest
Research interests include Pluripotent Stem Cells Research, CRISPR and Genetic Engineering, Zebrafish Biomedical Research Applications, and Chronic Myeloid Leukemia Treatments.
h-index
128
citations
79,153
works
645
NIH funding
primary concept
Biology
email

Recent publications

Design of soluble Notch agonists that drive T cell development and boost immunity
Cell 2025cited by 12position: lastdoi
The dynamics of hematopoiesis over the human lifespan
Nature Methods 2024cited by 35position: middledoi
Maturation and persistence of CAR T cells derived from human pluripotent stem cells via chemical inhibition of G9a/GLP
Cell stem cell 2024cited by 17position: lastdoi
Dynamic nucleolar phase separation influenced by non-canonical function of LIN28A instructs pluripotent stem cell fate decisions
Nature Communications 2024cited by 14position: middledoi
Generation of Functional iPSC-Derived CAR-T Cells for Cancer Immunotherapy Via G9a/GLP Inhibition
Blood 2024cited by 3position: lastdoi
In Vivo Reprogramming of Adult Liver Sinusoidal Vascular Endothelial Cells into a Hematopoietic Stem and Progenitor Cell Niche
Blood 2023cited by 1position: middledoi
EZH1 repression generates mature iPSC-derived CAR T cells with enhanced antitumor activity
Cell stem cell 2022cited by 89position: lastdoi
CellComm infers cellular crosstalk that drives haematopoietic stem and progenitor cell development
Nature Cell Biology 2022cited by 28position: lastdoi
Developmental maturation of the hematopoietic system controlled by a Lin28b-let-7-Cbx2 axis
Cell Reports 2022cited by 23position: middledoi
Hypoxic, glycolytic metabolism is a vulnerability of B-acute lymphoblastic leukemia-initiating cells
Cell Reports 2022cited by 15position: middledoi
ISSCR Guidelines for Stem Cell Research and Clinical Translation: The 2021 update
Stem Cell Reports 2021cited by 339position: middledoi
Evidence generation and reproducibility in cell and gene therapy research: A call to action
Molecular Therapy — Methods & Clinical Development 2021cited by 22position: middledoi
SARS-CoV-2 viral load is associated with increased disease severity and mortality
Nature Communications 2020cited by 974position: middledoi
The Toughest Triage — Allocating Ventilators in a Pandemic
New England Journal of Medicine 2020cited by 732position: lastdoi
Pancreatic circulating tumor cell profiling identifies LIN28B as a metastasis driver and drug target
Nature Communications 2020cited by 88position: middledoi
LIN28B regulates transcription and potentiates MYCN-induced neuroblastoma through binding to ZNF143 at target gene promotors
Proceedings of the National Academy of Sciences 2020cited by 65position: middledoi
Diversification of reprogramming trajectories revealed by parallel single-cell transcriptome and chromatin accessibility sequencing
Science Advances 2020cited by 56position: middledoi
Mitochondrial and Redox Modifications in Huntington Disease Induced Pluripotent Stem Cells Rescued by CRISPR/Cas9 CAGs Targeting
Frontiers in Cell and Developmental Biology 2020cited by 39position: middledoi
Calmodulin inhibitors improve erythropoiesis in Diamond-Blackfan anemia
Science Translational Medicine 2020cited by 39position: middledoi
Transcriptome Dynamics of Hematopoietic Stem Cell Formation Revealed Using a Combinatorial Runx1 and Ly6a Reporter System
Stem Cell Reports 2020cited by 12position: middledoi
3126 – SINGLE CELL SEQUENCING OF MLL-REARRANGED LEUKEMIA REVEALS MECHANISMS OF LEUKEMIA INITIATING CELL PLASTICITY
Experimental Hematology 2020cited by 0position: middledoi
Induced pluripotent stem cells in disease modelling and drug discovery
Nature Reviews Genetics 2019cited by 673position: lastdoi
Stem Cells in the Treatment of Disease
New England Journal of Medicine 2019cited by 239position: lastdoi
The Lin28/let-7 Pathway Regulates the Mammalian Caudal Body Axis Elongation Program
Developmental Cell 2019cited by 75position: lastdoi
Author Correction: Epoxyeicosatrienoic acids enhance embryonic haematopoiesis and adult marrow engraftment
Nature 2019cited by 9position: middledoi
Small-Molecule Inhibitors Disrupt let-7 Oligouridylation and Release the Selective Blockade of let-7 Processing by LIN28
Cell Reports 2018cited by 115position: middledoi
Reconstruction of complex single-cell trajectories using CellRouter
Nature Communications 2018cited by 94position: lastdoi
Regulation of embryonic haematopoietic multipotency by EZH1
Nature 2018cited by 89position: lastdoi
Building Capacity for a Global Genome Editing Observatory: Institutional Design
Trends in biotechnology 2018cited by 31position: middledoi
Building Capacity for a Global Genome Editing Observatory: Conceptual Challenges
Trends in biotechnology 2018cited by 30position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Thorsten M. Schlaeger · Boston Children's Hospital18 papers (2012–2025)Leonard I. Zon · Harvard University16 papers (2012–2024)James J. Collins · Broad Institute of MIT and Harvard13 papers (2012–2022)Edroaldo Lummertz da Rocha · Pro Persona11 papers (2014–2024)Hu Li · University of Hong Kong11 papers (2012–2020)R. Grant Rowe · Boston Children's Hospital11 papers (2015–2025)Patrick Cahan · Johns Hopkins University10 papers (2012–2020)Trista E. North · Harvard Stem Cell Institute10 papers (2018–2025)Alejandro De Los Angeles · Broad Institute9 papers (2012–2018)Peter G. Kim · Massachusetts Institute of Technology8 papers (2012–2016)Yuin‐Han Loh · Agency for Science, Technology and Research7 papers (2012–2020)Areum Han · Boston Children's Hospital7 papers (2016–2022)Stuart H. Orkin · Boston Children's Hospital7 papers (2012–2022)Patricia Sousa · Editas Medicine (United States)7 papers (2016–2020)Ng Shyh‐Chang · Chinese Academy of Sciences7 papers (2012–2015)Samantha A. Morris · Brigham and Women's Hospital6 papers (2012–2015)Marc T. Seligson · Cleveland Clinic6 papers (2013–2016)Caroline Kubaczka · Harvard Stem Cell Institute5 papers (2020–2024)Hao Zhu · Chinese Academy of Medical Sciences & Peking Union Medical College5 papers (2012–2015)Mohamad Najia · Massachusetts Institute of Technology5 papers (2022–2025)